Crescent Biopharma Balance Sheet (2013-2026) | CBIO

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
118.85M101.92M90.25M76.52M60.20M51.60M47.87M65.00M58.04M49.41M41.79M31.28M22.40M14.40M34.77M22.43M133.26M213.19M189.16M
Short-term Investments (Quarter)
Cash & Current Investments (Quarter)
118.85M101.92M90.25M76.52M60.20M51.60M47.87M65.00M58.04M49.41M41.79M31.28M22.40M14.40M34.77M22.43M133.26M213.19M189.16M
Receivables - Net (Quarter)
18.00M
Receivables - Other (Quarter)
0.00M0.00M0.00M0.00M0.12M0.09M0.14M0.23M0.22M0.19M0.18M0.11M0.08M0.05M0.14M0.08M
Receivables (Quarter)
0.14M18.00M
Prepaid Assets (Quarter)
0.52M2.21M0.27M0.46M1.02M2.22M0.40M2.29M1.36M1.81M2.00M0.86M0.59M0.80M0.04M0.30M1.58M1.30M5.46M6.40M
Current Assets (Quarter)
120.31M104.13M90.79M77.46M61.26M53.85M50.71M68.09M60.37M52.01M43.79M33.27M23.86M15.65M34.80M5.99M154.23M134.56M236.66M195.56M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.49M0.43M0.37M0.35M0.33M0.29M0.24M0.20M0.17M0.13M0.19M0.78M0.85M0.93M
Other Non-Current Assets (Quarter)
0.05M0.05M1.56M2.22M0.05M0.81M0.05M0.05M0.05M0.05M0.15M0.15M0.14M0.05M0.81M0.11M1.25M0.11M1.16M
Non-Current Assets (Quarter)
4.06M3.81M3.56M4.00M3.78M2.11M1.10M0.84M1.45M1.19M1.53M0.94M0.56M0.05M0.81M3.21M3.71M3.64M3.57M
Assets (Quarter)
124.38M107.94M94.35M81.46M65.04M55.96M51.81M68.92M61.82M53.20M45.32M34.20M24.42M15.70M35.62M5.99M157.43M138.27M240.29M199.13M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.17M1.39M2.11M2.28M1.27M0.85M0.97M0.48M0.24M0.33M0.87M0.76M0.95M0.58M7.22M0.10M5.02M2.56M0.14M
Payables (Quarter)
1.17M1.39M2.11M2.28M1.27M0.85M0.97M0.48M0.24M0.33M0.87M0.76M0.95M0.58M7.22M0.10M5.02M2.56M0.14M
Accumulated Expenses (Quarter)
8.13M1.70M0.35M9.48M0.47M0.42M0.30M1.10M5.51M1.72M5.23M0.57M2.96M0.44M2.23M0.00M7.61M8.96M16.34M4.43M
Other Accumulated Expenses (Quarter)
0.19M0.16M0.09M0.11M0.08M0.06M0.04M0.06M0.02M0.02M0.01M0.05M
Current Leases (Quarter)
0.95M0.97M1.00M1.03M1.06M1.08M0.92M0.65M0.82M0.75M0.74M0.63M0.45M0.26M0.20M0.42M0.43M0.45M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)
4.16M3.12M
Total Current Liabilities (Quarter)
10.25M9.66M11.82M12.78M8.94M7.75M8.88M6.74M6.57M6.39M6.84M5.29M4.36M4.32M9.61M2.62M16.75M20.30M36.07M14.19M
Non-Current Liabilities
Non-Current Debt (Quarter)
37.48M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
4.00M4.00M4.00M
Operating Leases (Quarter)
1.44M1.18M0.92M0.65M0.38M0.10M0.45M0.26M0.07M1.64M1.30M1.21M1.09M
Other Non-Current Liabilities (Quarter)
0.41M0.54M
Total Non-Current Liabilities (Quarter)
11.68M10.84M12.74M13.43M9.32M7.84M8.88M6.74M7.02M6.65M6.90M5.29M4.36M4.32M47.10M
Total Liabilities (Quarter)
12.09M11.38M12.74M13.43M9.32M7.84M8.88M6.74M7.02M6.65M6.90M5.29M4.36M4.32M47.10M2.62M18.18M21.63M37.28M15.28M
Shareholder's Equity
Total Debt (Quarter)
37.48M
Common Equity (Quarter)
112.29M96.57M81.60M68.03M55.73M48.12M42.93M62.18M54.80M46.55M38.41M28.91M20.06M-1.30M-15.48M-30.16M139.25M116.64M203.01M183.85M
Shareholder's Equity (Quarter)
112.29M96.57M81.60M68.03M55.73M48.12M42.93M62.18M54.80M46.55M38.41M28.91M20.06M-1.30M-15.48M-30.16M139.25M116.64M203.01M183.85M
Liabilities and Shareholders Equity (Quarter)
124.38M107.94M94.35M81.46M65.04M55.96M51.81M68.92M61.82M53.20M45.32M34.20M24.42M15.70M35.62M5.99M157.43M138.27M240.29M199.13M
Retained Earnings (Quarter)
-338.14M-355.48M-372.90M-387.55M-400.82M-409.34M-419.59M-429.90M-438.20M-447.40M-456.49M-467.22M-477.32M-487.14M-17.87M-496.71M-54.80M-79.41M-171.81M-195.10M
Preferred Shares (Quarter)
4.00M4.00M4.00M4.00M
Treasury Shares (Quarter)
0.59M0.40M0.35M0.27M0.22M0.21M0.20M0.12M0.12M0.12M0.12M0.06M0.05M0.05M0.25M0.12M0.44M0.74M0.07M